Sethabutr O, Brown A E, Panyim S, Kain K C, Webster H K, Echeverria P
Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
J Infect Dis. 1992 Jul;166(1):145-8. doi: 10.1093/infdis/166.1.145.
Detection of Plasmodium falciparum by polymerase chain reaction (PCR) was evaluated in 33 P. falciparum-infected patients with two different amplification systems over 5-7 days of curative treatment. In the K1-14 system, a P. falciparum DNA fragment of 206 bp was detected, and in the circumsporozoite (CS) system, a fragment of 800 bp was detected. The K1-14 and CS systems identified 95% and 93%, respectively, of 103 microscopically identified specimens; both systems detected as few as 11 parasites/microliters among these specimens. Specimens from 20 smear- and history-negative controls were all negative by both PCR systems. The K1-14 and CS systems detected P. falciparum DNA in 53% and 20%, respectively, of blood films collected on the first day and 3% and 0 of the blood films collected on the fourth day after reversion to microscopic negative. The simultaneous use of two independent PCR systems to monitor patients during curative treatment of P. falciparum infections convincingly demonstrated that P. falciparum DNA was present transiently in the blood of infected patients at a time when the parasite could no longer be detected microscopically.
在33例恶性疟原虫感染患者接受5至7天的根治性治疗期间,使用两种不同的扩增系统通过聚合酶链反应(PCR)对恶性疟原虫进行检测。在K1-14系统中,检测到一个206bp的恶性疟原虫DNA片段,在环子孢子(CS)系统中,检测到一个800bp的片段。K1-14和CS系统分别在103份经显微镜鉴定的标本中鉴定出95%和93%;在这些标本中,两个系统都能检测到低至11个寄生虫/微升。来自20例涂片和病史均为阴性的对照样本在两种PCR系统中均为阴性。K1-14和CS系统分别在治疗第一天采集的血片中检测到53%和20%的恶性疟原虫DNA,在恢复为显微镜阴性后的第四天采集的血片中分别检测到3%和0。在恶性疟原虫感染的根治性治疗期间,同时使用两种独立的PCR系统监测患者,令人信服地证明,在显微镜下无法再检测到寄生虫时,恶性疟原虫DNA仍短暂存在于感染患者的血液中。